Advertisement

Endoscopic Treatment of Esophageal Varices: Simultaneous Combination of Endoscopic Injection Sclerotherapy and Endoscopic Variceal Ligation for Prevention of Recurrence

  • Fumio Chikamori
Chapter

Abstract

The Takase method of endoscopic injection sclerotherapy (EIS) obliterates esophagogastric varices and their associated blood supply. Obliteration of blood supply routes contributes to lower the recurrence of esophageal varices after EIS. In endoscopic injection sclerotherapy with simultaneous ligation (EISL), EIS is performed first followed by endoscopic variceal ligation (EVL). The suction of the injection site is maintained after EIS to facilitate EVL. Band ligation is performed at the site of injection. As the blood flow is blocked by ligation, EISL allows the sclerosant to remain at the site. It is less invasive and requires fewer sessions and less sclerosant. There is less chance of bleeding from the injection site as the variceal puncture is ligated. EISL is indicated for esophageal varices, especially for pipeline varices, cardiac varices which drain into esophageal varices, and/or special type of varices.

Keywords

Endoscopic injection sclerotherapy with simultaneous ligation Esophagogastric varices Endoscopic injection sclerotherapy Endoscopic variceal ligation 

Notes

Acknowledgments

I thank Dr. Niranjan Sharma PhD, Mornington Health Centre, Dunedin, New Zealand, for helpful comments.

References

  1. 1.
    Takase Y, Ozaki A, Orii K, Nagoshi K, Okamura T, Iwasaki Y. Injection sclerotherapy of esophageal varices for patients undergoing emergency and elective surgery. Surgery. 1982;92:474–9.PubMedGoogle Scholar
  2. 2.
    Takase Y, Shibuya S, Chikamori F, Orii K, Iwasaki Y. Recurrence factors studied by percutaneous transhepatic portography before and after endoscopic sclerotherapy for esophageal varices. Hepatology. 1990;11:348–52.CrossRefGoogle Scholar
  3. 3.
    Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med. 1992;326:1527–32.CrossRefGoogle Scholar
  4. 4.
    Nishikawa Y, Hosokawa Y, Doi T, Shima S, Miyoshi M, Ohnishi T, et al. Simultaneous combination of endoscopic sclerotherapy and endoscopic ligation for esophageal varices. Gastrointest Endosc. 1995;42:358–60.CrossRefGoogle Scholar
  5. 5.
    Nishikawa Y, Hosokawa Y, Doi T, Endo H, Tanimizu M, Hyodo I, et al. Evaluation of endoscopic injection sclerotherapy with and without simultaneous ligation for the treatment of esophageal varices. J Gastroenterol. 1999;34:159–62.CrossRefGoogle Scholar
  6. 6.
    Shigemitsu T, Yoshida T, Harada T, Takeo Y, Nakamura H, Okita K. Endoscopic injection sclerotherapy with ligation versus endoscopic injection sclerotherapy alone in the management of esophageal varices: a prospective randomized trial. Hepatogastroenterology. 2000;47:733–7.PubMedGoogle Scholar
  7. 7.
    Umehara M, Onda M, Tajiri T, Toba M, Yoshida H, Yamashita K. Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: a prospective randomized study. Gastrointestinal Endosc. 1999;50:7–12.CrossRefGoogle Scholar
  8. 8.
    Chikamori F, Kawashima T, Takase Y, Inoue A, Okamoto H, Kuniyoshi N, et al. Endoscopic therapy and interventional radiology for pipeline esophageal varices (in Japanese). Endosc Dig. 2010;22:1764–71.Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Fumio Chikamori
    • 1
  1. 1.Department of SurgeryTano HospitalKochiJapan

Personalised recommendations